HK Stock Market Move | XPENG-W(09868) fell nearly 3% during trading hours, with March deliveries down 17.44% year-on-year.
Xiaopeng Group-W (09868) fell nearly 3%, as of the time of writing, it dropped by 2.2% to HKD 66.75, with a turnover of HKD 650 million.
XPENG-W (09868) fell by nearly 3%, dropping by 2.2% as of the time of writing, to HK$66.75, with a trading volume of HK$6.5 billion.
On the news front, on April 1st, new energy vehicle startups successively released their delivery results for March. Among them, Xiaopeng Motors delivered 27,415 vehicles in March, a year-on-year decrease of 17.44%, making it the only new energy vehicle manufacturer with negative growth; the cumulative deliveries in the first quarter reached 62,682 vehicles, a year-on-year decrease of over 30%, meeting the delivery guidance. According to 21st Century Business Herald, from multiple independent sources, Wei Bin, Vice President of Xiaopeng Group and Head of Intelligent Cockpit, has recently resigned due to family reasons. Before his resignation, Wei Bin's main responsibility was to promote the intelligent cockpit based on the VLM (Visual Language Model) large model.
Related Articles

China Securities Co., Ltd. reviews the A-share market in the first quarter of 2026: This bull market is more forward-looking in terms of regulation and will take timely measures to address overheated trading.

Jiangsu Aidea Pharmaceutical Group (688488.SH): A clinical trial for a new type 1 drug ACC085 injection in the field of HIV treatment will be conducted.

Subsidiary company of Shenzhen Nanshan Power (000037.SZ) plans to invest in the construction of a 300MW/600MWh independent energy storage power station in the Cuiheng New Area of Zhongshan City (Phases Two and Three) project.
China Securities Co., Ltd. reviews the A-share market in the first quarter of 2026: This bull market is more forward-looking in terms of regulation and will take timely measures to address overheated trading.

Jiangsu Aidea Pharmaceutical Group (688488.SH): A clinical trial for a new type 1 drug ACC085 injection in the field of HIV treatment will be conducted.

Subsidiary company of Shenzhen Nanshan Power (000037.SZ) plans to invest in the construction of a 300MW/600MWh independent energy storage power station in the Cuiheng New Area of Zhongshan City (Phases Two and Three) project.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


